Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data

Genome Medicine

Volumn 3, Issue 1, 2011, Pages

  Wang, Joanne H ^a   Pappas, Derek ^a   De Jager, Philip L ^b,c   Pelletier, Daniel ^a   de Bakker, Paul I W ^c,d   Kappos, Ludwig ^e   Polman, Chris H ^f   Chibnik, Lori B ^b   Bahlo, Melanie ^g   Hafler, David A ^h   Matthews, Paul M ⁱ   Hauser, Stephen L ^a,j   Baranzini, Sergio E ^a   Oksenberg, Jorge R ^a,j   Booth, David R ^g   Broadley, Simon A ^g   Brown, Matthew A ^g   Foote, Simon J ^g   Griffiths, Lyn R ^g   Kilpatrick, Trevor J ^g   Lechner Scott, Jeanette ^g   Moscato, Pablo ^g   Perreau, Victoria M ^g   Rubio, Justin P ^g   Scott, Rodney J ^g   Stankovich, Jim ^g   Stewart, Graeme J ^g   Taylor, Bruce V ^g   Wiley, James ^g   Danoy, Patrick ^g   Butzkueven, Helmut ^g   Slee, Mark ^g   Greer, Judith ^g   Kermode, Allan ^g   Carroll, William ^g   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^g UNIVERSITY OF MELBOURNE   (Australia)

^h YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ HAMMERSMITH HOSPITAL   (United Kingdom)

^j UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IONOTROPIC RECEPTOR;

ADULT; ARTICLE; BRAIN DAMAGE; CELL ADHESION; CELL COMMUNICATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC DATABASE; GENETIC MARKER; GENETIC RISK; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NERVOUS SYSTEM DEVELOPMENT; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EID: 78651462023     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm217     Document Type: Article

References (44)

1. Goodin DS. The causal cascade to multiple sclerosis: a model for MS pathogenesis. PLoS One 2009, 4:e4565. 10.1371/journal.pone.0004565, 2644781, 19242548.
2. Oksenberg JR, Baranzini SE, Sawcer S, Hauser SL. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat Rev Genet 2008, 9:516-526. 10.1038/nrg2395, 18542080.
3. Compston A, Coles A. Multiple sclerosis. Lancet 2008, 372:1502-1517. 10.1016/S0140-6736(08)61620-7, 18970977.
4. Risch N. Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet 1990, 46:222-228. 1684987, 2301392.
5. Guo SW. Inflation of sibling recurrence-risk ratio, due to ascertainment bias and/or overreporting. Am J Hum Genet 1998, 63:252-258. 10.1086/301928, 1377249, 9634526.
6. Sawcer S, Ban M, Wason J, Dudbridge F. What role for genetics in the prediction of multiple sclerosis?. Ann Neurol 2010, 67:3-10. 10.1002/ana.21911, 2830384, 20186855.
7. Hemminki K, Li X, Sundquist J, Hillert J, Sundquist K. Risk for multiple sclerosis in relatives and spouses of patients diagnosed with autoimmune and related conditions. Neurogenetics 2009, 10:5-11. 10.1007/s10048-008-0156-y, 18843511.
8. Willer CJ, Dyment DA, Risch NJ, Sadovnick AD, Ebers GC. Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci USA 2003, 100:12877-12882. 10.1073/pnas.1932604100, 240712, 14569025.
9. Hansen T, Skytthe A, Stenager E, Petersen HC, Bronnum-Hansen H, Kyvik KO. Concordance for multiple sclerosis in Danish twins: an update of a nationwide study. Mult Scler 2005, 11:504-510. 10.1191/1352458505ms1220oa, 16193885.
10. Hawkes CH, Macgregor AJ. Twin studies and the heritability of MS: a conclusion. Mult Scler 2009, 15:661-667. 10.1177/1352458509104592, 19482860.
11. International Multiple Sclerosis Genetics Consortium Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007, 357:851-862. 10.1056/NEJMoa073493, 17660530, International Multiple Sclerosis Genetics Consortium.
12. Australian and New Zealand Multiple Sclerosis Genetics Consortium Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 2009, 41:824-828. 10.1038/ng.396, 19525955, Australian and New Zealand Multiple Sclerosis Genetics Consortium.
13. International Multiple Sclerosis Genetics Consortium Refining genetic associations in multiple sclerosis. Lancet Neurol 2008, 7:567-569. 10.1016/S1474-4422(08)70122-4, 2696028,2696028, 18565446, International Multiple Sclerosis Genetics Consortium.
14. Baranzini SE, Wang J, Gibson RA, Galwey N, Naegelin Y, Barkhof F, Radue EW, Lindberg RL, Uitdehaag BM, Johnson MR, Angelakopoulou A, Hall L, Richardson JC, Prinjha RK, Gass A, Geurts JJ, Kragt J, Sombekke M, Vrenken H, Qualley P, Lincoln RR, Gomez R, Caillier SJ, George MF, Mousavi H, Guerrero R, Okuda DT, Cree BA, Green AJ, Waubant E, et al. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet 2009, 18:767-778. 10.1093/hmg/ddn388, 19010793.
15. Casaccia-Bonnefil P, Pandozy G, Mastronardi F. Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: a contribution to the current debate on disease pathogenesis. Prog Neurobiol 2008, 86:368-378. 2656687, 18930111.
16. Otaegui D, Baranzini SE, Armananzas R, Calvo B, Munoz-Culla M, Khankhanian P, Inza I, Lozano JA, Castillo-Trivino T, Asensio A, Olaskoaga J, de Munain AL. Differential micro RNA expression in PBMC from multiple sclerosis patients. PLoS One 2009, 4:e6309. 10.1371/journal.pone.0006309, 2708922, 19617918.
17. Brassat D, Motsinger AA, Caillier SJ, Erlich HA, Walker K, Steiner LL, Cree BA, Barcellos LF, Pericak-Vance MA, Schmidt S, Gregory S, Hauser SL, Haines JL, Oksenberg JR, Ritchie MD. Multifactor dimensionality reduction reveals gene-gene interactions associated with multiple sclerosis susceptibility in African Americans. Genes Immun 2006, 7:310-315. 10.1038/sj.gene.6364299, 16625214.
18. Gregersen JW, Kranc KR, Ke X, Svendsen P, Madsen LS, Thomsen AR, Cardon LR, Bell JI, Fugger L. Functional epistasis on a common MHC haplotype associated with multiple sclerosis. Nature 2006, 443:574-577.
19. Yeo TW, De Jager PL, Gregory SG, Barcellos LF, Walton A, Goris A, Fenoglio C, Ban M, Taylor CJ, Goodman RS, Walsh E, Wolfish CS, Horton R, Traherne J, Beck S, Trowsdale J, Caillier SJ, Ivinson AJ, Green T, Pobywajlo S, Lander ES, Pericak-Vance MA, Haines JL, Daly MJ, Oksenberg JR, Hauser SL, Compston A, Hafler DA, Rioux JD, Sawcer S. A second major histocompatibility complex susceptibility locus for multiple sclerosis. Ann Neurol 2007, 61:228-236. 10.1002/ana.21063, 2737610, 17252545.
20. Barcellos LF, Sawcer S, Ramsay PP, Baranzini SE, Thomson G, Briggs F, Cree BC, Begovich AB, Villoslada P, Montalban X, Uccelli A, Savettieri G, Lincoln RR, DeLoa C, Haines JL, Pericak-Vance MA, Compston A, Hauser SL, Oksenberg JR. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet 2006, 15:2813-2824. 10.1093/hmg/ddl223, 16905561.
21. Lincoln MR, Ramagopalan SV, Chao MJ, Herrera BM, Deluca GC, Orton SM, Dyment DA, Sadovnick AD, Ebers GC. Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility. Proc Natl Acad Sci USA 2009, 106:7542-7547. 2678609, 19380721.
22. Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, Kwiatkowski DP, McCarthy MI, Ouwehand WH, Samani NJ, Todd JA, Donnelly P, Barrett JC, Davison D, Easton D, Evans DM, Leung HT, Marchini JL, Morris AP, Spencer CC, Tobin MD, Attwood AP, Boorman JP, Cant B, Everson U, Hussey JM, Jolley JD, Knight AS, Koch K, Meech E, et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007, 39:1329-1337. 10.1038/ng.2007.17, 2680141, 17952073.
23. Okuda DT, Srinivasan R, Oksenberg JR, Goodin DS, Baranzini SE, Beheshtian A, Waubant E, Zamvil SS, Leppert D, Qualley P, Lincoln R, Gomez R, Caillier S, George M, Wang J, Nelson SJ, Cree BA, Hauser SL, Pelletier D. Genotype-phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures. Brain 2009, 132:250-259. 10.1093/brain/awn301, 2638695, 19022862.
24. De Jager PL, Jia X, Wang J, de Bakker PI, Ottoboni L, Aggarwal NT, Piccio L, Raychaudhuri S, Tran D, Aubin C, Briskin R, Romano S, Baranzini SE, McCauley JL, Pericak-Vance MA, Haines JL, Gibson RA, Naeglin Y, Uitdehaag B, Matthews PM, Kappos L, Polman C, McArdle WL, Strachan DP, Evans D, Cross AH, Daly MJ, Compston A, Sawcer SJ, Weiner HL, et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet 2009, 41:776-782. 10.1038/ng.401, 2757648, 19525953.
25. De Jager PL, Baecher-Allan C, Maier LM, Arthur AT, Ottoboni L, Barcellos L, McCauley JL, Sawcer S, Goris A, Saarela J, Yelensky R, Price A, Leppa V, Patterson N, de Bakker PI, Tran D, Aubin C, Pobywajlo S, Rossin E, Hu X, Ashley CW, Choy E, Rioux JD, Pericak-Vance MA, Ivinson A, Booth DR, Stewart GJ, Palotie A, Peltonen L, Dubois B, et al. The role of the CD58 locus in multiple sclerosis. Proc Natl Acad Sci USA 2009, 106:5264-5269. 10.1073/pnas.0813310106, 2664005, 19237575.
26. Baranzini SE, Galwey NW, Wang J, Khankhanian P, Lindberg R, Pelletier D, Wu W, Uitdehaag BM, Kappos L, Polman CH, Matthews PM, Hauser SL, Gibson RA, Oksenberg JR, Barnes MR. Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum Mol Genet 2009, 18:2078-2090. 10.1093/hmg/ddp120, 2678928, 19286671.
27. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460:748-752.
28. The International HapMap Project. Nature 2003, 426:789-796. 10.1038/nature02168, 14685227.
29. MACH Algorithm. , http://www.sph.umich.edu/csg/abecasis/MACH/download/
30. Hosmer DW, Lemeshow S. Applied Logistic Regression 2000, New York: Wiley, 2.
31. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003, 4:P3. 10.1186/gb-2003-4-5-p3, 12734009.
32. Zhang B, Schmoyer D, Kirov S, Snoddy J. GOTree Machine (GOTM): a web-based platform for interpreting sets of interesting genes using Gene Ontology hierarchies. BMC Bioinformatics 2004, 5:16. 10.1186/1471-2105-5-16, 373441, 14975175.
33. Rioux JD, Goyette P, Vyse TJ, Hammarstrom L, Fernando MM, Green T, De Jager PL, Foisy S, Wang J, de Bakker PI, Leslie S, McVean G, Padyukov L, Alfredsson L, Annese V, Hafler DA, Pan-Hammarstrom Q, Matell R, Sawcer SJ, Compston AD, Cree BA, Mirel DB, Daly MJ, Behrens TW, Klareskog L, Gregersen PK, Oksenberg JR, Hauser SL. Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases. Proc Natl Acad Sci USA 2009, 106:18680-18685. 10.1073/pnas.0909307106, 2773992, 19846760.
34. Hensiek AE, Seaman SR, Barcellos LF, Oturai A, Eraksoi M, Cocco E, Vecsei L, Stewart G, Dubois B, Bellman-Strobl J, Leone M, Andersen O, Bencsik K, Booth D, Celius EG, Harbo HF, Hauser SL, Heard R, Hillert J, Myhr KM, Marrosu MG, Oksenberg JR, Rajda C, Sawcer SJ, Sorensen PS, Zipp F, Compston DA. Familial effects on the clinical course of multiple sclerosis. Neurology 2007, 68:376-383. 10.1212/01.wnl.0000252822.53506.46, 17261686.
35. Sawcer S. The complex genetics of multiple sclerosis: pitfalls and prospects. Brain 2008, 131:3118-3131. 10.1093/brain/awn081, 2639203, 18490360.
36. Nannya Y, Taura K, Kurokawa M, Chiba S, Ogawa S. Evaluation of genome-wide power of genetic association studies based on empirical data from the HapMap project. Hum Mol Genet 2007, 16:2494-2505. 10.1093/hmg/ddm205, 17666406.
37. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 2007, 61:288-299. 10.1002/ana.21117, 17444504.
38. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol 2007, 61:504-513. 10.1002/ana.21141, 17492755.
39. De Jager PL, Chibnik LB, Cui J, Reischl J, Lehr S, Simon KC, Aubin C, Bauer D, Heubach JF, Sandbrink R, Tyblova M, Lelkova P, Havrdova E, Pohl C, Horakova D, Ascherio A, Hafler DA, Karlson EW. Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score. Lancet Neurol 2009, 8:1111-1119. 10.1016/S1474-4422(09)70275-3, 19879194.
40. Byun E, Caillier SJ, Montalban X, Villoslada P, Fernandez O, Brassat D, Comabella M, Wang J, Barcellos LF, Baranzini SE, Oksenberg JR. Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis. Arch Neurol 2008, 65:337-344. 10.1001/archneurol.2008.47, 18195134.
41. Comabella M, Craig DW, Morcillo-Suarez C, Rio J, Navarro A, Fernandez M, Martin R, Montalban X. Genome-wide scan of 500,000 single-nucleotide polymorphisms among responders and nonresponders to interferon beta therapy in multiple sclerosis. Arch Neurol 2009, 66:972-978. 10.1001/archneurol.2009.150, 19667218.
42. Trapp BD, Stys PK. Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol 2009, 8:280-291. 10.1016/S1474-4422(09)70043-2, 19233038.
43. Draghici S, Khatri P, Tarca AL, Amin K, Done A, Voichita C, Georgescu C, Romero R. A systems biology approach for pathway level analysis. Genome Res 2007, 17:1537-1545. 10.1101/gr.6202607, 1987343, 17785539.
44. Roxburgh RH, Seaman SR, Masterman T, Hensiek AE, Sawcer SJ, Vukusic S, Achiti I, Confavreux C, Coustans M, le Page E, Edan G, McDonnell GV, Hawkins S, Trojano M, Liguori M, Cocco E, Marrosu MG, Tesser F, Leone MA, Weber A, Zipp F, Miterski B, Epplen JT, Oturai A, Sorensen PS, Celius EG, Lara NT, Montalban X, Villoslada P, Silva AM, et al. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 2005, 64:1144-1151.